SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001092307-03-000154
Filing Date
2003-03-10
Accepted
2003-03-10 10:09:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 ANNUAL FILING npspharm2.txt SC 13G/A 16811
  Complete submission text file 0001092307-03-000154.txt   18604
Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Subject) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-46256 | Film No.: 03597234
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address TAUNUSANLAGE 12 D-60325 FRANKFURT AM MAIN I8
Business Address TAUNUSANLAGE 12 D-60325 FRANKFURT AM MAIN GE I8
DEUTSCHE BANK AG\ (Filed by) CIK: 0000948046 (see all company filings)

IRS No.: 13294498 | State of Incorp.: I8